AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $55,000 | -24.7% | 115,925 | -9.8% | 0.00% | – |
| Q4 2021 | $73,000 | -64.0% | 128,479 | +5.1% | 0.00% | – |
| Q3 2021 | $203,000 | -1.5% | 122,224 | -0.7% | 0.00% | – |
| Q2 2021 | $206,000 | +1484.6% | 123,079 | +448.2% | 0.00% | – |
| Q4 2019 | $13,000 | -64.9% | 22,450 | -69.7% | 0.00% | – |
| Q3 2019 | $37,000 | +311.1% | 74,034 | +198.7% | 0.00% | – |
| Q2 2019 | $9,000 | -86.8% | 24,788 | -80.0% | 0.00% | – |
| Q1 2019 | $68,000 | +36.0% | 123,681 | -3.6% | 0.00% | – |
| Q4 2018 | $50,000 | -90.4% | 128,333 | -87.6% | 0.00% | – |
| Q3 2018 | $522,000 | -73.0% | 1,031,767 | +17.4% | 0.00% | -100.0% |
| Q2 2018 | $1,932,000 | +27.4% | 878,609 | +96.9% | 0.00% | 0.0% |
| Q1 2018 | $1,516,000 | – | 446,175 | +368639.7% | 0.00% | – |
| Q4 2017 | $0 | – | 121 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 121 | -99.8% | 0.00% | – |
| Q2 2017 | $31,000 | +287.5% | 60,875 | +442.1% | 0.00% | – |
| Q1 2017 | $8,000 | -60.0% | 11,229 | -54.0% | 0.00% | – |
| Q4 2016 | $20,000 | -69.2% | 24,428 | -72.5% | 0.00% | – |
| Q3 2016 | $65,000 | -52.6% | 88,948 | -17.3% | 0.00% | – |
| Q2 2016 | $137,000 | – | 107,602 | +370941.4% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 29 | -99.9% | 0.00% | – |
| Q4 2015 | $159,000 | +488.9% | 45,626 | +375.2% | 0.00% | – |
| Q3 2015 | $27,000 | +237.5% | 9,602 | +170.9% | 0.00% | – |
| Q2 2015 | $8,000 | -68.0% | 3,544 | +2.5% | 0.00% | – |
| Q1 2015 | $25,000 | +127.3% | 3,457 | +0.9% | 0.00% | – |
| Q4 2014 | $11,000 | -15.4% | 3,426 | -10.1% | 0.00% | – |
| Q3 2014 | $13,000 | -55.2% | 3,812 | +5.7% | 0.00% | – |
| Q2 2014 | $29,000 | -93.1% | 3,608 | -94.5% | 0.00% | – |
| Q1 2014 | $418,000 | +523.9% | 65,857 | +589.7% | 0.00% | – |
| Q4 2013 | $67,000 | -75.3% | 9,548 | -73.7% | 0.00% | – |
| Q3 2013 | $271,000 | – | 36,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |